Read by QxMD icon Read


Yufei Liang, Yuefang Ren, Zeqiu Wan, Lihua Guo, Jie Dong, Yun Chen, Liping Lv
This study aims to determine whether clinical evaluation of improved MyoSure hysteroscopic tissue removal system can remove type II submucosal myomas with safety and high success rate of the first operation.Fifty-three patients with type II submucosal myomas hospitalized in the Huzhou Maternity and Child Care Hospital were enrolled in this study. The submucosal myomas were with the diameter of >2 cm and ≤5 cm. All patients have surgical indications.Fifty-one of 53 hysteromyomas were successfully resected through 1-time operation...
December 2017: Medicine (Baltimore)
Peter Rosenblatt, Sara Barcia, Anthony DiSciullo, Hussein Warda
Objective: To compare the diagnostic suitability of endometrial tissues obtained from postmenopausal women using the MyoSure Lite tissue removal system versus conventional curettage. Materials and methods: Endometrial tissue was sampled in hysteroscopically normal extirpated uteri from seven postmenopausal women (65.9±6.6 years old) using both hysteroscopicguided morcellation and curettage (two quadrants/uterus with each method). Endometrial sampling was performed immediately after hysterectomy for benign reasons unrelated to uterine pathology...
2017: International Journal of Women's Health
Salvatore Giovanni Vitale, Fabrizio Sapia, Agnese Maria Chiara Rapisarda, Gaetano Valenti, Fabrizia Santangelo, Diego Rossetti, Benito Chiofalo, Giuseppe Sarpietro, Valentina Lucia La Rosa, Onofrio Triolo, Marco Noventa, Salvatore Gizzo, Antonio Simone Laganà
Hysteroscopic surgery is the actual gold standard treatment for several types of intrauterine pathologies, including submucous myomas (SMs). To date, the availability of Hysteroscopic Tissue Removal systems (HTRs) opened a new scenario. Based on these elements, the aim of this article is to review the available evidence about HTRs for the management of SMs. We included 8 papers (3 prospective studies and 5 retrospective studies). A total of 283 women underwent intrauterine morcellation of SM: 208 were treated using MyoSure and 75 using Truclear 8...
2017: BioMed Research International
Michael D Scheiber, Serena H Chen
Background: Hysteroscopic morcellation removes uterine pathology under direct visualization with continuous real-time tissue fragment removal. Objective: The aim of this study was to explore the feasibility of hysteroscopic morcellation across a diverse set of facilities, including both surgical and office-based settings. Design: This was a prospective, single-arm, multicenter registry development (Canadian Task Force classification II-3). Materials and Methods: Thirty-four U.S. obstetrics and gynecology facilities enrolled subjects into the registry...
December 1, 2016: Journal of Gynecologic Surgery
A Arnold, A Ketheeswaran, M Bhatti, E Nesbitt-Hawes, J Abbott
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
P Rosenblatt, A DiScuillo, H Warda, S Barcia
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
S Chen, A Chang, C Adkins
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
R Malik, S Rizwan, B Rizk
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
S K Rajesh, C Guyer
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
Deidre Meulenbroeks, Tjalina W O Hamerlynck, Sema Saglam-Kara, Nadia K Van Rijssel, Huib A A M Van Vliet, Benedictus C Schoot
STUDY OBJECTIVE: To compare polyp resection time and myoma resection rate using 2 hysteroscopic tissue removal systems. DESIGN: Prospective randomized in vitro trial (Canadian Task Force classification I). SETTING: Clinical skills laboratory of a non-university teaching hospital. SAMPLES: Polyp surrogate and myoma tissue. INTERVENTIONS: Hysteroscopic tissue removal with the TRUCLEAR system, using the TRUCLEAR INCISOR 2...
January 1, 2017: Journal of Minimally Invasive Gynecology
Bijan W Salari, Bala Bhagavath, Michael L Galloway, Austin D Findley, Jerome L Yaklic, Steven R Lindheim
OBJECTIVE: To report a step-by-step technique to using a hysteroscopic morcellator to safely gain access into the intrauterine cavity in two patients with severe cervical stenosis and concomitant intrauterine pathology. DESIGN: Video article introducing the hysteroscopic morcellator for overcoming severe cervical stenosis. SETTING: Academic-based practice. PATIENT(S): A 36-year-old G0 female with primary infertility and uterine polyps and a 34-year-old G0 female with uterine polyps and a difficult trial transfer before undergoing an IVF cycle...
November 2016: Fertility and Sterility
Amy Arnold, Ashradha Ketheeswaran, Mominah Bhatti, Erin Nesbitt-Hawes, Jason Abbott
OBJECTIVE: To determine the effectiveness of the MyoSure intrauterine mechanical morcellator device for removal of intrauterine pathology. DESIGN: Prospective cohort study (Canadian Task Force classification II-2). INTERVENTION: This study was performed at the Royal Hospital for Women and Prince of Wales Private Hospital, Sydney, Australia. All women undergoing hysteroscopic removal of intrauterine pathology using the MyoSure device between January 2013 and June 2015 were included...
March 2016: Journal of Minimally Invasive Gynecology
Menelik M H Lee, Tomoko Matsuzono
INTRODUCTION: Hysteroscopic management of submucosal fibroids using the intrauterine morcellation technique is increasingly being adopted worldwide but no literature concerning its safety and efficacy is available within our local population. We aimed to determine the safety, satisfaction, and efficiency of hysteroscopic intrauterine morcellation of submucosal fibroids, and to compare this technique with conventional hysteroscopic monopolar loop resection to identify its potential benefits...
February 2016: Hong Kong Medical Journal, Xianggang Yi Xue za Zhi
Andrea S Lukes, Kelly H Roy, James B Presthus, Michael P Diamond, Jay M Berman, Kenneth A Konsker
PURPOSE: To evaluate the efficacy of two cervical block protocols for pain management during hysteroscopic removal of intrauterine polyps and myomas using the MyoSure(®) device. PATIENTS AND METHODS: This was a randomized, comparative treatment trial conducted by five private Obstetrics and Gynecology practices in the USA. Forty premenopausal women aged 18 years and older were randomized to receive either a combination para/intracervical block protocol of 37 cc local anesthetic administered at six injections sites in association with the application of topic 1% lidocaine gel, or an intracervical block protocol of 22 cc local anesthetic administered at three injections sites without topical anesthetic, for pain management during hysteroscopic removal of intrauterine polyps and/or a single type 0 or type 1 submucosal myoma ≤3 cm...
2015: International Journal of Women's Health
R Keriakos, S Khalid
No abstract text is available yet for this article.
May 2016: Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology
Malcolm G Munro
OBJECTIVE: To demonstrate a technique designed to expand the capabilities of hysteroscopic intrauterine morcellators to deep type 1 and type 2 lesions. The technique comprises "release" of the tumor using a bipolar radiofrequency needle, followed by dissection and extraction with an electromechanical morcellator, all under local anesthesia. DESIGN: Description of technique using images and video (Canadian Task Force classification Class III). SETTING: Office uterine procedure and imaging center; academic medical center...
January 2016: Journal of Minimally Invasive Gynecology
Patrick McIlwaine, Bernadette McElhinney, Krishnan Andrew Karthigasu, Roger Hart
BACKGROUND: The Myosure resectoscope has been in use since 2009. Our unit is the first in Australia to describe the use of the Myosure device in the outpatient setting to resect endometrial polyps. AIM: To compare patient satisfaction and pain scores of pre- and postmenopausal women undergoing outpatient removal of endometrial polyps using the Myosure device. MATERIAL AND METHODS: Public hospital based prospective study. Patients (n=42) who opted to have resection of endometrial polyps under local anaethesia were recruited...
October 2015: Australian & New Zealand Journal of Obstetrics & Gynaecology
Marco Noventa, Emanuele Ancona, Michela Quaranta, Amerigo Vitagliano, Erich Cosmi, Donato D'Antona, Salvatore Gizzo
The aim of this study was to analyze all available evidence regarding the use of intrauterine morcellator (IUM), for treatment of the most prevalent intrauterine benign lesions, compared to both traditional resectoscopy and conventional outpatient operative hysteroscopy in terms of safety, efficacy, contraindications, perioperative complications, operating time, and estimated learning curve. We reported data regarding a total of 1185 patients. Concerning polypectomy and myomectomy procedures, IUM systems demonstrated a better outcome in terms of operative time and fluid deficit compared to standard surgical procedures...
October 2015: Reproductive Sciences
A Hamidouche, M Vincienne, T Thubert, C Trichot, G Demoulin, A L Rivain, X Deffieux
OBJECTIVE: The treatment of endometrial polyps is based on hysteroscopic resection. The aim of the current study was to compare the results associated with hysteroscopic morcellation and those observed with bipolar loop resection. PATIENTS AND METHODS: A single-center observational retrospective comparative study was performed, including 25 patients who underwent hysteroscopic resection of endometrial polyps from January 2012 to December 2013. The mean size of polyp was 9...
February 2015: Gynécologie, Obstétrique & Fertilité
O Garbin, L Schwartz
A new technology recently appeared for the treatment of endo-uterine pathologies: hysteroscopic morcellators. It seemed to us useful to review this new technology. The morcellator we mostly experiment is the Myosure®, in 14 patients, with a median age of 40.5 years (28-58). The time of procedure went from 5 to 75 min with a median time at 26 min. The median of the total fluid deficit was 300 mL (0-1500 mL). A conversion in traditional resectoscopy happened in 4 cases (29%). This results are not so good as in literature...
December 2014: Gynécologie, Obstétrique & Fertilité
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"